Trial Details

COMPLETED
Basic Information
Clinical ID c3376
Identifier NCT02148718
Trial Title Rapidity of Response to Adalimumab Treatment in Patients With Crohn´s Disease
Trial URL Visit Original Page
Study Information
Study Results

YES

Conditions Moderate to Severe Crohn's Disease
Interventions BIOLOGICAL: adalimumab
Participant Information
Sponsor AbbVie
City -
Country/Region -
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT, OLDER_ADULT
Study Design
Study Type INTERVENTIONAL
Phase PHASE4
Time Information
Start Date 2014-06
Primary Completion Date 2016-08
Completion Date 2017-01